Clinical Trial Update: Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Paclitaxel, Carboplatin, and DMXAA in extensive-stage small cell lung cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Dimethylxanthenone Acetic Acid (Dimethylxanthenone Acetic Acid)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED